NCT01944345

Brief Summary

The registry has been designed as a prospective, observational program for patients undergoing lumbar or cervical fusion using VariLift device with the ultimate goal to aid in the development of strategic treatment pathways and improved patient care. All patients who agree to participate in the registry will sign an informed consent form and subsequently be treated by their surgeon with the VariLift device. Potential treatment procedures include bilateral posterior lumbar interbody fusion (PLIF), unilateral transforaminal lumbar interbody fusion (TLIF), or bilateral anterior lumbar interbody fusion (ALIF) for the lumbar spine, or cervical unilateral or bilateral ACDF procedure. Surgical procedures can be performed in either an inpatient or outpatient facility. It is anticipated that the VariLift devices will improve patient outcomes and lead to the development of treatment pathways to improve patient care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
69

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2013

Typical duration for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2013

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 6, 2013

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 17, 2013

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
8 months until next milestone

Results Posted

Study results publicly available

April 14, 2016

Completed
Last Updated

May 17, 2016

Status Verified

April 1, 2016

Enrollment Period

2.3 years

First QC Date

September 6, 2013

Results QC Date

January 6, 2016

Last Update Submit

April 14, 2016

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Oswestry Disability Index (ODI)/Neck Disability Index (NDI) Score Range 0-50

    ODI/NDI Score Range: 0-50 0-4 No disability 5-14 Mild disability 15-24 Moderate disability 25-34 Severe disability \>34 Complete disability

    Pre-operative and Post-operative 12 months post-operative

  • Change in VAS Pain

    VAS Pain comparison Preoperative vs post-operative of greater than or equal to 6. VAS PAIN SEVERITY SCALE ranges from 0-10. A score of zero (0) means 'no pain' and a ten (10) means 'worst imaginable pain'

    Pre-operative and Post-operative 12 months

Secondary Outcomes (1)

  • Radiological Assessment

    Post-operative follow up

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing spinal fusion using VariLift lumbar or cervical devices must be screened by the investigating surgeon for eligibility into the registry using the primary diagnosis parameters and the inclusion/exclusion criteria. In addition physicians must follow the associated VariLift Instructions for Use.

You may qualify if:

  • Patient is undergoing a procedure with unilateral or bilateral placement of VariLift
  • This is the first surgery at the index level
  • Patient has understood and signed the informed consent
  • Patient is skeletally mature

You may not qualify if:

  • Revision Surgery
  • Is a Worker's Compensation Case
  • Infection at the operative site
  • Sustained trauma with instability
  • Sustained fracture of the vertebra at any of the lumbar spinal levels
  • Has a primary diagnosis of degenerative or isthmic spondylolisthesis greater than Grade 1
  • Physically or mentally compromised (i.e., being currently treated for a psychiatric disorder, senile dementia, Alzheimer's disease, presence of alcohol or drug abuse)
  • Has a diagnosed systemic disease that would affect the subject's welfare or overall outcome of the clinical study (i.e., moderate to severe osteoporosis, Paget's disease, renal osteodystrophy, metastasis to vertebrae, adult onset diabetes, active rheumatoid arthritis, etc.)
  • Is an immunologically suppressed or receiving steroid in excess of usual doses
  • Is obese (as defined by a Body Mass Index (BMI) of \> 40 kg/m2 (BMI equals (weight in pounds x 703) / (height in inches x height in inches))
  • Has disabling and daily narcotic dependency greater than 18 months
  • Has a known malignancy
  • Has a known allergy to metal implants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02215, United States

Location

Foundation Surgical Hospital

San Antonio, Texas, 78229, United States

Location

Methodist Hospital

San Antonio, Texas, 78229, United States

Location

MeSH Terms

Conditions

Intervertebral Disc DegenerationSpondylolisthesisLymphoma, FollicularIntervertebral Disc Displacement

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal DiseasesSpondylolysisSpondylosisLymphoma, Non-HodgkinLymphomaNeoplasms by Histologic TypeNeoplasmsLymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesImmunoproliferative DisordersImmune System DiseasesHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Director, Quality & Regulatory Affairs
Organization
Wenzel Spine, Inc.

Study Officials

  • Warren Neely, MD

    The Methodist Hospital Research Institute

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
GT60
Restrictive Agreement
Yes

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 6, 2013

First Posted

September 17, 2013

Study Start

June 1, 2013

Primary Completion

September 1, 2015

Study Completion

September 1, 2015

Last Updated

May 17, 2016

Results First Posted

April 14, 2016

Record last verified: 2016-04

Data Sharing

IPD Sharing
Will not share

Data will not be shared

Locations